ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,08
-0,05%
Bitcoin
66 354,45
-0,43%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Nuo Therapeutics Inc (QB) (AURX)

  7. Nuo Therapeutics Inc (QB) (AURX) Actualités

AURX

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:AURX
DateHeureSourceTitreSymboleSociété
11/06/202422h26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
22/05/202418h40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202421h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
14/02/202419h58Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:AURXNuo Therapeutics Inc (QB)
12/02/202423h33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
20/12/202320h18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202315h37Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202323h10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/202312h08Edgar (US Regulatory)Annual Report (10-k)USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202200h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202214h36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202214h34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AURXNuo Therapeutics Inc (QB)
30/08/202214h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AURXNuo Therapeutics Inc (QB)
10/08/202219h29Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202214h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202214h02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AURXNuo Therapeutics Inc (QB)
19/05/202222h35Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AURXNuo Therapeutics Inc (QB)
27/04/202222h20Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:AURXNuo Therapeutics Inc (QB)
31/03/202222h47Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:AURXNuo Therapeutics Inc (QB)
21/03/202215h30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)USOTC:AURXNuo Therapeutics Inc (QB)
04/02/202223h03Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)USOTC:AURXNuo Therapeutics Inc (QB)
21/01/202217h29Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)USOTC:AURXNuo Therapeutics Inc (QB)
09/10/202021h30Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:AURXNuo Therapeutics Inc (QB)
13/11/201922h32Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/201922h21Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:AURXNuo Therapeutics Inc (QB)
04/08/201722h02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:AURXNuo Therapeutics Inc (QB)
30/06/201723h25Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AURXNuo Therapeutics Inc (QB)
20/04/201720h14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:AURXNuo Therapeutics Inc (QB)
11/04/201712h17Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AURXNuo Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:AURX

Dernières Valeurs Consultées

NASDAQ
NVDA
NVIDIA
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
USI
USTECH100
US Tech 100
EU
RI
Pernod Ricard
EU
AI
Air Liquide
EU
DG
Vinci
EU
BN
Danone
EU
EN
Bouygues
EU
GLE
Societe Generale
EU
HO
Thales
EU
PX1
CAC 40
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés